160415
3-(2-吡啶基)-5,6-二苯基-1,2,4-三嗪
≥99%
别名:
5,6-二苯基-3-(2-吡啶基)-1,2,4-三嗪, PDT
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C20H14N4
化学文摘社编号:
分子量:
310.35
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
213-878-7
Beilstein/REAXYS Number:
542151
MDL number:
Assay:
≥99%
InChI
1S/C20H14N4/c1-3-9-15(10-4-1)18-19(16-11-5-2-6-12-16)23-24-20(22-18)17-13-7-8-14-21-17/h1-14H
InChI key
OTMYLOBWDNFTLO-UHFFFAOYSA-N
SMILES string
c1ccc(cc1)-c2nnc(nc2-c3ccccc3)-c4ccccn4
assay
≥99%
mp
191-193 °C (lit.)
functional group
phenyl
Quality Level
General description
3-（2-吡啶基）-5,6-二苯基-1,2,4-三嗪（PDT）与高氯酸铜（II）在乙醇中反应，可生成[Cu（PDT）2（CLO4）2]。
Application
在分光光度法测定酸和酸性溶液中的铁的过程中，使用3-（2-吡啶基）-5,6-二苯基-1,2,4-三嗪作为显色提取试剂。 它也被用作HPLC方法中的柱前衍生试剂，从而通过UV吸光度对Fe（II）进行测定。
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
M A Sirotkina et al.
Scientific reports, 9(1), 6492-6492 (2019-04-26)
Prediction of tumour treatment response may play a crucial role in therapy selection and optimization of its delivery parameters. Here we use optical coherence angiography (OCA) as a minimally-invasive, label-free, real-time bioimaging method to visualize normal and pathological perfused vessels
Synthesis and structural charaterization of a Cu (II) complex with 3-(2-pyridyl)-5, 6-diphenyl-1, 2, 4-triazine (PDPT).
Soudi AA, et al.
Journal of Coordination Chemistry, 58(17), 1631-1637 (2005)
Spectrophotometric determination of iron in acids and acidic solutions by an extraction formation reaction involving 3-(2-pyridyl)-5, 6-diphenyl-1, 2, 4-triazine as the chromogenic-extraction reagent.
Chriswell CD and Schilt AA.
Analytical Chemistry, 46(8), 992-996 (1974)
Thomas J van Rijssen et al.
PloS one, 13(8), e0202549-e0202549 (2018-08-25)
To assess parameters on optical coherence tomography (OCT), and their correlation with best-corrected visual acuity (BCVA) in patients with non-resolving central serous chorioretinopathy (CSC). For 25 non-resolving CSC patients treated with photodynamic therapy (PDT), the thickness of retinal layers was
Yvonne H W Derks et al.
Theranostics, 11(4), 1527-1541 (2021-01-08)
Incomplete resection of prostate cancer (PCa) occurs in 15%-50% of PCa patients. Disease recurrence negatively impacts oncological outcome. The use of radio-, fluorescent-, or photosensitizer-labeled ligands to target the prostate-specific membrane antigen (PSMA) has become a well-established method for the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持